The Administrative Core is charged with leadership, oversight, fiscal, and general administrative responsibility for the Oregon Alzheimer Disease Center (OADC). The OADC Director works closely with the Executive Committee of the Center, which is composed of all the Core Leaders and other key OADC personnel. The Administrative Core coordinates the six cores of the Center through structured, regular meetings and interim reports. Members of individual Cores, having duties and necessary interactions within other related units of the Center, facilitate the integration of the OADC on a daily basis. In addition to managerial and supervisory duties, the Administrative Core also seeks to ensure that the OADC is positioned to respond to the needs of the greater community of scientists and other interested individuals engaged in activities relevant to research on Alzheimer disease and related disorders, especially as they relate to uncompromised brain aging and incipient or early dementia. This includes advising and encouraging young investigators, as well as relating to the concerns and requirements of established scientists with regard to their research. The Core also seeks to foster the movement of talented investigators from other fields into the brain aging and dementia arena. This process is facilitated by the OADC Pilot Project Grant mechanism organized annually by the Administrative Core. Overview of the general direction and quality of the Center is achieved through oversight and advice of the National Institute on Aging and two committees: the External and Internal Advisory Committees. The External Review process brings in an outside External Review Committee of experts to critically review the progress of the Center and issue a formal report. Similarly, but with a different, yet complementary perspective, the Internal Advisory Committee (composed of prominent local scientists and community leaders) also provides review and oversight to the OADC. Members of both review committees are also used to advise the OADC Director and Core Leaders on an as needed basis as well.

Public Health Relevance

The Administrative Core of the Oregon Alzheimer Disease Center provides the necessary organizational structure, scientific direction and leadership to effectively operate the entire research center. In providing oversight and stewardship of the overall mission of the center sound fiscal, scientific and educational policies and practices are achieved targeted toward the goal of understanding the causes of dementia and ultimately their treatments.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
3P30AG008017-23S1
Application #
8514262
Study Section
Special Emphasis Panel (ZAG1-ZIJ-4)
Project Start
1997-01-01
Project End
2014-03-31
Budget Start
2012-05-01
Budget End
2013-03-31
Support Year
23
Fiscal Year
2012
Total Cost
$22,988
Indirect Cost
$8,061
Name
Oregon Health and Science University
Department
Type
DUNS #
096997515
City
Portland
State
OR
Country
United States
Zip Code
97239
Lusardi, Theresa A; Wiedrick, Jack T; Malone, Molly et al. (2018) Analytics of Cerebrospinal Fluid MicroRNA Quantitative PCR Studies. Mol Neurobiol :
Leach, Julia M; Mancini, Martina; Kaye, Jeffrey A et al. (2018) Day-to-Day Variability of Postural Sway and Its Association With Cognitive Function in Older Adults: A Pilot Study. Front Aging Neurosci 10:126
Davis, Jeremy J (2018) Performance validity in older adults: Observed versus predicted false positive rates in relation to number of tests administered. J Clin Exp Neuropsychol 40:1013-1021
Mogg, Adrian J; Eessalu, Thomas; Johnson, Megan et al. (2018) In Vitro Pharmacological Characterization and In Vivo Validation of LSN3172176 a Novel M1 Selective Muscarinic Receptor Agonist Tracer Molecule for Positron Emission Tomography. J Pharmacol Exp Ther 365:602-613
Lin, Ming; Gong, Pinghua; Yang, Tao et al. (2018) Big Data Analytical Approaches to the NACC Dataset: Aiding Preclinical Trial Enrichment. Alzheimer Dis Assoc Disord 32:18-27
Tulloch, Jessica; Leong, Lesley; Chen, Sunny et al. (2018) APOE DNA methylation is altered in Lewy body dementia. Alzheimers Dement 14:889-894
Wang, Lucy Y; Raskind, Murray A; Wilkinson, Charles W et al. (2018) Associations between CSF cortisol and CSF norepinephrine in cognitively normal controls and patients with amnestic MCI and AD dementia. Int J Geriatr Psychiatry 33:763-768
Kaur, Antarpreet; Edland, Steven D; Peavy, Guerry M (2018) The MoCA-Memory Index Score: An Efficient Alternative to Paragraph Recall for the Detection of Amnestic Mild Cognitive Impairment. Alzheimer Dis Assoc Disord 32:120-124
Kirson, Noam Y; Scott Andrews, J; Desai, Urvi et al. (2018) Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer's Disease. J Alzheimers Dis 61:295-307
Brenowitz, Willa D; Han, Fang; Kukull, Walter A et al. (2018) Treated hypothyroidism is associated with cerebrovascular disease but not Alzheimer's disease pathology in older adults. Neurobiol Aging 62:64-71

Showing the most recent 10 out of 482 publications